Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma

Histopathology

Volumn 63, Issue 4, 2013, Pages 474-481

  Jung, Woon Yong ^a   Kang, Youngran ^a   Lee, Hyunjoo ^b   Mok, Young Jae ^a   Kim, Han Kyeom ^a   Kim, Aeree ^a   Kim, Baek hui ^a  

^a Korea University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Adenocarcinoma; CD44; Epithelial mesenchymal transition; Moesin; Stomach

Indexed keywords

HERMES ANTIGEN; MOESIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STAINING; STOMACH ADENOCARCINOMA; SURVIVAL PREDICTION; TISSUE MICROARRAY; TUMOR INVASION;

ADENOCARCINOMA; CD44; EPITHELIAL-MESENCHYMAL TRANSITION; MOESIN; STOMACH;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84884725327     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12202     Document Type: Article

References (22)

1. Kurozumi K, Nishida T, Nakao K, Nakahara M, Tsujimoto M. Expression of CD44 variant 6 and lymphatic invasion: importance to lymph node metastasis in gastric cancer. World J. Surg. 1998; 22; 853-857; discussion 857-858.
2. Okayama H, Kumamoto K, Saitou K et al. CD44v6, MMP-7 and nuclear CDX2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer. Oncol. Rep. 2009; 22; 745-755.
3. Songun I, Litvinov SV, van de Velde CJ, Pals ST, Hermans J, van Krieken JH. Loss of ep-cam (co17-1a) expression predicts survival in patients with gastric cancer. Br. J. Cancer 2005; 92; 1767-1772.
4. Hofmann M, Rudy W, Zoller M et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res. 1991; 51; 5292-5297.
5. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 1994; 126; 391-401.
6. Takahashi E, Nagano O, Ishimoto T et al. Tumor necrosis factor-I regulates transforming growth factor-β-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction. J. Biol. Chem. 2010; 285; 4060-4073.
7. Kobayashi H, Sagara J, Kurita H et al. Clinical significance of cellular distribution of moesin in patients with oral squamous cell carcinoma. Clin. Cancer Res. 2004; 10; 572-580.
8. Charafe-Jauffret E, Monville F, Bertucci F et al. Moesin expression is a marker of basal breast carcinomas. Int. J. Cancer 2007; 121; 1779-1785.
9. Torer N, Kayaselcuk F, Nursal TZ et al. Adhesion molecules as prognostic markers in pancreatic adenocarcinoma. J. Surg. Oncol. 2007; 96; 419-423.
10. Kobel M, Gradhand E, Zeng K et al. Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma. Int. J. Gynecol. Pathol. 2006; 25; 121-130.
11. Ou-Yang M, Liu HR, Zhang Y, Zhu X, Yang Q. ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. Biochimie 2011; 93; 954-961.
12. Edge SB, American Joint Committee on Cancer. AJCC cancer staging manual, 7th edn. New York, NY: Springer, 2010.
13. Aaltonen LA, Hamilton SR, World Health Organization, International Agency for Research on Cancer. Pathology and genetics of tumours of the digestive system. Lyon/Oxford: IARC Press/Oxford University Press (distributor), 2000.
14. Lankes W, Griesmacher A, Grunwald J, Schwartz-Albiez R, Keller R. A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation. Biochem. J. 1988; 251; 831-842.
15. Zhu L, Hatakeyama J, Zhang B, Makdisi J, Ender C, Forte JG. Novel insights of the gastric gland organization revealed by chief cell specific expression of moesin. Am. J. Physiol. Gastrointest. Liver Physiol. 2009; 296; G185-G195.
16. Ueyama H, Yao T, Nakashima Y et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am. J. Surg. Pathol. 2010; 34; 609-619.
17. Wang CC, Liau JY, Lu YS, Chen JW, Yao YT, Lien HC. Differential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transition. Histopathology 2012; 61; 78-87.
18. Iwatsuki M, Mimori K, Yokobori T et al. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010; 101; 293-299.
19. Martin-Villar E, Megias D, Castel S, Yurrita MM, Vilaro S, Quintanilla M. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J. Cell Sci. 2006; 119; 4541-4553.
20. Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat. Rev. Cancer 2011; 11; 254-267.
21. Doventas A, Bilici A, Demirell F, Ersoy G, Turna H, Doventas Y. Prognostic significance of CD44 and C-ERB-B2 protein overexpression in patients with gastric cancer. Hepato-gastroenterology 2012; 59; 2196-2201.
22. Martin-Villar E, Fernandez-Munoz B, Parsons M et al. Podoplanin associates with CD44 to promote directional cell migration. Mol. Biol. Cell 2010; 21; 4387-4399.